ponsegromab
Sponsors
Pfizer
Conditions
CachexiaColorectal CancerFatigueHealthyLoss of AppetiteMetastatic Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerNon-small Cell Lung Cancer (NSCLC)
Phase 1
A Study to Learn How the Study Medicine (Ponsegromab) is Changed and Eliminated From Healthy Chinese Adults
CompletedNCT05685264
Start: 2023-01-18End: 2023-07-07Updated: 2024-10-01
A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss
Not yet recruitingNCT07663630
Start: 2026-10-23End: 2029-07-01Target: 80Updated: 2026-09-08
Phase 2
Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15
CompletedNCT05546476
Start: 2022-11-21End: 2025-04-23Updated: 2026-06-03
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecruitingNCT06989437
Start: 2025-10-03End: 2029-12-10Target: 982Updated: 2026-08-24